Literature DB >> 23420180

Malignant synaptic growth and Alzheimer's disease.

Ehren L Newman1, Christopher F Shay, Michael E Hasselmo.   

Abstract

In this article, we will describe the malignant synaptic growth hypothesis of Alzheimer's disease. Originally presented in 1994, the hypothesis remains a viable model of the functional and biophysical mechanisms underlying the development and progression of Alzheimer's disease. In this article, we will refresh the model with references to relevant empirical support that has been generated in the intervening two decades since it's original presentation. We will include discussion of its relationship, in terms of points of alignment and points of contention, to other models of Alzheimer's disease, including the cholinergic hypothesis and the tau and β-amyloid models of Alzheimer's disease. Finally, we propose several falsifiable predictions made by the malignant synaptic growth hypothesis and describe the avenues of treatment that hold the greatest promise under this hypothesis.

Entities:  

Keywords:  Alzheimer’s; acetylcholine; computational model; dementia; excitotoxicity; long-term potentiation; neurofibrillary tangles; plasticity; tau; β amyloid

Year:  2012        PMID: 23420180      PMCID: PMC3571723          DOI: 10.2217/fnl.12.47

Source DB:  PubMed          Journal:  Future Neurol        ISSN: 1479-6708


  82 in total

1.  An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission.

Authors:  Jana K Shirey; Zixiu Xiang; Darren Orton; Ashley E Brady; Kari A Johnson; Richard Williams; Jennifer E Ayala; Alice L Rodriguez; Jürgen Wess; David Weaver; Colleen M Niswender; P Jeffrey Conn
Journal:  Nat Chem Biol       Date:  2007-12-02       Impact factor: 15.040

Review 2.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

3.  Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

Authors:  Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

Review 4.  Alzheimer's disease: maladaptive synaptoplasticity hypothesis.

Authors:  D Neill
Journal:  Neurodegeneration       Date:  1995-06

5.  Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.

Authors:  Karin Boekhoorn; Dick Terwel; Barbara Biemans; Peter Borghgraef; Olof Wiegert; Ger J A Ramakers; Koos de Vos; Harm Krugers; Takami Tomiyama; Hiroshi Mori; Marian Joels; Fred van Leuven; Paul J Lucassen
Journal:  J Neurosci       Date:  2006-03-29       Impact factor: 6.167

6.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

Review 7.  Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease.

Authors:  Abraham Fisher
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

Review 8.  Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory.

Authors:  Paul R Turner; Kate O'Connor; Warren P Tate; Wickliffe C Abraham
Journal:  Prog Neurobiol       Date:  2003-05       Impact factor: 11.685

Review 9.  Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Reisa Sperling
Journal:  Ann N Y Acad Sci       Date:  2007-02       Impact factor: 5.691

10.  Plasticity of hippocampal circuitry in Alzheimer's disease.

Authors:  J W Geddes; D T Monaghan; C W Cotman; I T Lott; R C Kim; H C Chui
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

View more
  6 in total

1.  Excessive/Aberrant and Maladaptive Synaptic Plasticity: A Hypothesis for the Pathogenesis of Alzheimer's Disease.

Authors:  Shigeki Kawabata
Journal:  Front Aging Neurosci       Date:  2022-07-05       Impact factor: 5.702

Review 2.  Can BACE1 inhibition mitigate early axonal pathology in neurological diseases?

Authors:  Xiao-Xin Yan; Chao Ma; Wei-Ping Gai; Huaibin Cai; Xue-Gang Luo
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 3.  Modulation of Hippocampal Circuits by Muscarinic and Nicotinic Receptors.

Authors:  Holger Dannenberg; Kimberly Young; Michael Hasselmo
Journal:  Front Neural Circuits       Date:  2017-12-13       Impact factor: 3.492

4.  Multivariate dynamical modelling of structural change during development.

Authors:  Gabriel Ziegler; Gerard R Ridgway; Sarah-Jayne Blakemore; John Ashburner; Will Penny
Journal:  Neuroimage       Date:  2016-12-13       Impact factor: 6.556

5.  Switching between internal and external modes: A multiscale learning principle.

Authors:  Christopher J Honey; Ehren L Newman; Anna C Schapiro
Journal:  Netw Neurosci       Date:  2017-12-01

6.  Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer's Disease.

Authors:  Will Penny; Jorge Iglesias-Fuster; Yakeel T Quiroz; Francisco Javier Lopera; Maria A Bobes
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.